Singapore’s Health Sciences Authority is requesting stakeholder comments by June 28, 2012, on new guidance pertaining to the registration of Class B medical devices. The guidance, which was drafted following the April 20 announcement of enhancements to Singapore’s medical device regulatory framework, provides additional information about two new evaluation routes for registration: expedited and immediate. The new draft guidance also includes information about eligibility criteria and submission requirements for each evaluation route, as well as “processing flow.” Class B medical devices “are typically of low-moderate risk and include devices such as hypodermic needles, suction apparatus, pregnancy test kits, and ultrasound imaging equipment.”